PMC:7652766 / 88837-89114
Annnotations
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T434 | 0-277 | Sentence | denotes | Although no consensus has been reached on its efficacy, dosage, or administration period, the literature includes some case reports, case series, and observational studies reporting a protective effect of the lopinavir/ritonavir combination in COVID-19 patients (110, 307–312). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3216 | 253-261 | Species | denotes | patients | Tax:9606 |
| 3217 | 182-183 | Gene | denotes | a | Gene:351 |
| 3222 | 209-228 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 3225 | 244-252 | Disease | denotes | COVID-19 | MESH:C000657245 |